Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Mesenchymal stromal cells (MSC) are tested in clinical trials to treat graft versus host disease (GvHD) after stem cell transplantation (SCT). In vitro studies demonstrated MSC's broad immunosuppressive activity. As infections represent a major risk after SCT, it is important to understand the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lucchini, Giovanna, Dander, Erica, Pavan, Fabio, Di Ceglie, Irene, Balduzzi, Adriana, Perseghin, Paolo, Gaipa, Giuseppe, Algarotti, Alessandra, Introna, Martino, Rambaldi, Alessandro, Rovelli, Attilio, Biondi, Andrea, Biagi, Ettore, D'Amico, Giovanna
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369546/
https://ncbi.nlm.nih.gov/pubmed/22701127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/690236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados